Related references
Note: Only part of the references are listed.Prolactin Drives a Dynamic STAT5A/HDAC6/HMGN2 Cis-Regulatory Landscape Exploitable in ER+ Breast Cancer
Justin M. Craig et al.
ENDOCRINOLOGY (2021)
The human intermediate prolactin receptor is a mammary proto-oncogene
Jacqueline M. Grible et al.
NPJ BREAST CANCER (2021)
Unphosphorylated STAT3 in heterochromatin formation and tumor suppression in lung cancer
Pranabananda Dutta et al.
BMC CANCER (2020)
Inhibition of the Activity of Cyclophilin A Impedes Prolactin Receptor-Mediated Signaling, Mammary Tumorigenesis, and Metastases
Shawn Hakim et al.
ISCIENCE (2020)
Separation of breast cancer and organ microenvironment transcriptomes in metastases
Mohammad A. Alzubi et al.
BREAST CANCER RESEARCH (2019)
Implications of STAT3 and STAT5 signaling on gene regulation and chromatin remodeling in hematopoietic cancer
Bettina Wingelhofer et al.
LEUKEMIA (2018)
The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update
Enis Afgan et al.
NUCLEIC ACIDS RESEARCH (2018)
Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells
Suzanne M. Schauwecker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Salmon provides fast and bias-aware quantification of transcript expression
Rob Patro et al.
NATURE METHODS (2017)
STAT5-mediated chromatin interactions in superenhancers activate IL-2 highly inducible genes: Functional dissection of the Il2ra gene locus
Peng Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Unphosphorylated STAT3 regulates the antiproliferative, antiviral, and gene-inducing actions of type I interferons
Susan R. Pfeffer et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Soft Agar Colony Formation Assay as a Hallmark of Carcinogenesis
Feng Du et al.
BIO-PROTOCOL (2017)
HDAC6 Deacetylates HMGN2 to Regulate Stat5a Activity and Breast Cancer Growth
Terry R. Medler et al.
MOLECULAR CANCER RESEARCH (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
SREBP-1 is an independent prognostic marker and promotes invasion and migration in breast cancer
Jisheng Bao et al.
ONCOLOGY LETTERS (2016)
PAK-dependent STAT5 serine phosphorylation is required for BCR-ABL-induced leukemogenesis
A. Berger et al.
LEUKEMIA (2014)
Identification of STAT5A and STAT5B Target Genes in Human T Cells
Takahiro Kanai et al.
PLOS ONE (2014)
Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERa and STAT5
Raghuveer Kavarthapu et al.
ONCOTARGET (2014)
The Soft Agar Colony Formation Assay
Stanley Borowicz et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
The Prolactin Receptor Transactivation Domain Is Associated with Steroid Hormone Receptor Expression and Malignant Progression of Breast Cancer
Alyson A. Fiorillo et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
Aleix Prat et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Differential Contributions of STAT5A and STAT5B to Stress Protection and Tyrosine Kinase Inhibitor Resistance of Chronic Myeloid Leukemia Stem/Progenitor Cells
Luana Casetti et al.
CANCER RESEARCH (2013)
Completely Humanizing Prolactin Rescues Infertility in Prolactin Knockout Mice and Leads to Human Prolactin Expression in Extrapituitary Mouse Tissues
Heather R. Christensen et al.
ENDOCRINOLOGY (2013)
Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth
Xiaoyu Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
CDK8-Mediated STAT1-S727 Phosphorylation Restrains NK Cell Cytotoxicity and Tumor Surveillance
Eva Maria Putz et al.
CELL REPORTS (2013)
Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes
Amy R. Peck et al.
BREAST CANCER RESEARCH (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
HMGN2 Inducibly Binds a Novel Transactivation Domain in Nuclear PRLr to Coordinate Stat5a-Mediated Transcription
Alyson A. Fiorillo et al.
MOLECULAR ENDOCRINOLOGY (2011)
Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer
Lisa M. Arendt et al.
BREAST CANCER RESEARCH (2011)
Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation
Katrin Friedbichler et al.
BLOOD (2010)
Role of nuclear unphosphorylated STAT3 in angiotensin II type 1 receptor-induced cardiac hypertrophy
Hong Yue et al.
CARDIOVASCULAR RESEARCH (2010)
MCF-7 breast carcinoma cells do not express caspase-3
Reiner U. Jaenicke
BREAST CANCER RESEARCH AND TREATMENT (2009)
Role of c-Myb during Prolactin-Induced Signal Transducer and Activator of Transcription 5a Signaling in Breast Cancer Cells
Feng Fang et al.
ENDOCRINOLOGY (2009)
Dendritic Cells Require STAT-1 Phosphorylated at Its Transactivating Domain for the Induction of Peptide-Specific CTL
Andreas Pilz et al.
JOURNAL OF IMMUNOLOGY (2009)
New mechanisms for PRLr action in breast cancer
Charles V. Clevenger et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2009)
Quantification of PRL/Stat5 signaling with a novel pGL4-CISH reporter
Feng Fang et al.
BMC BIOTECHNOLOGY (2008)
Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation
Haiyan R. Qin et al.
CANCER RESEARCH (2008)
Unphosphorylated STATs go nuclear
Stephen Brown et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Constitutive nuclear import of latent and activated STAT5a by its coiled coil domain
Janaki Iyer et al.
FASEB JOURNAL (2008)
STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-α3
L Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Isolation of unique STAT5 targets by chromatin immunoprecipitation-based gene identification
EA Nelson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Prolactin induces ERα-positive and ERα-negative mammary cancer in transgenic mice
TA Rose-Hellekant et al.
ONCOGENE (2003)
Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells
H Yamashita et al.
ONCOGENE (2003)
Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity
L Varinou et al.
IMMUNITY (2003)
Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance
E Devarajan et al.
ONCOGENE (2002)
Role of serine phosphorylation of Stat5a in prolactin-stimulated β-casein gene expression
H Yamashita et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene
M Chatterjee-Kishore et al.
EMBO JOURNAL (2000)
Serine phosphorylation of STATs
T Decker et al.
ONCOGENE (2000)
Stat5a serine phosphorylation -: Serine 779 is constitutively phosphorylated in the mammary gland, and serine 725 phosphorylation influences prolactin-stimulated in vitro DNA binding activity
I Beuvink et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
